These support scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. Grants support basic, pre-clinical and translational research that can be directly applied to optimising cancer immunotherapy in the clinic.
Candidates must be qualified scientists who hold a faculty appointment as a tenure-track assistant professor, or higher rank, at the time of the award activation. There are no citizenship requirements for candidates, and research may be conducted at medical schools and research centres throughout the world.
Grants are worth up to USD 100,000 each per year for two years. Funding covers salary, technical assistance, supplies, capital equipment or scientific travel costs. Indirect costs are not covered.
Closing Date: 1 November 2018